BioNTech SE (BNTX) Net Income (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -488.85% |
| Sep 30, 2025 | 120.86% |
| Jun 30, 2025 | 12.41% |
| Mar 31, 2025 | -280.18% |
| Dec 31, 2024 | 27.46% |
| Sep 30, 2024 | 125.01% |
| Jun 30, 2024 | -129.77% |
| Mar 31, 2024 | -140.52% |
| Dec 31, 2023 | 191.78% |
| Sep 30, 2023 | 254.47% |
| Jun 30, 2023 | -121.15% |
| Mar 31, 2023 | -57.84% |
| Dec 31, 2022 | 29.18% |
| Sep 30, 2022 | -43.15% |
| Jun 30, 2022 | -55.49% |
| Mar 31, 2022 | 96.37% |
| Dec 31, 2021 | 110.20% |
| Sep 30, 2021 | -72.79% |
| Jun 30, 2021 | 219.66% |
| Mar 31, 2021 | 3,750,585,741.62% |
| Dec 31, 2020 | -100.00% |
| Sep 30, 2020 | 149.21% |
| Jun 30, 2020 | 64.98% |
| Mar 31, 2020 | 354,951.65% |
| Dec 31, 2019 | -99.95% |
| Sep 30, 2019 | -40.46% |
| Jun 30, 2019 | 21.45% |
| Mar 31, 2019 | 189.05% |
| Dec 31, 2018 | -290.49% |